Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 4 Nov 2025 |
| Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley | 31 Oct 2025 |
| Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira | 31 Oct 2025 |
| Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox | 31 Oct 2025 |
| Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley | 29 Oct 2025 |
| Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic | 21 Oct 2025 |